Literature DB >> 12673891

Interleukin-6, soluble interleukin-2 receptor and soluble interleukin-6 receptor in the sera of patients with different histological patterns of rheumatoid synovitis.

P A Klimiuk1, S Sierakowski, R Latosiewicz, J P Cylwik, B Cylwik, J Skowronski, J Chwiecko.   

Abstract

OBJECTIVE: The present study was conducted to investigate whether the serum levels of interleukin 6 (IL-6), soluble IL-2 receptor (sIL-2R) and sIL-6R are associated with the morphological appearance of rheumatoid arthritis (RA).
METHODS: Using the ELISA technique we measured the IL-6, sIL-2R and sIL-6R concentrations in the serum of 34 patients with RA and 28 patients with osteoarthritis (OA). Histological analysis of synovial samples distinguished 2 types of rheumatoid synovitis. Twenty-one RA specimens presented diffuse infiltrates of mononuclear cells without any specific microanatomical organization. In remaining 13 samples the formation of lymphocytic follicles with germinal center-like structures was found.
RESULTS: Serum levels of IL-6, sIL-2R and sIL-6R were elevated in patients with RA compared to the OA control group (p < 0.001, p < 0.001 and p < 0.05 respectively). Concentrations of IL-6 and sIL-2R were highest in the serum of RA patients with follicular synovitis in comparison to patients with diffuse synovitis (p < 0.001 and p < 0.01 respectively) and could distinguish RA patients with these two histological variants of the disease. Serum levels of IL-6 and sIL-2R correlated with markers of disease activity such as ESR and CRP levels. In addition, the clinical data suggest a more severe disease among RA patients with follicular synovitis.
CONCLUSION: Distinct histological types of rheumatoid synovitis associated with unique serum concentrations of IL-6 and sIL-2R reflect levels of disease activity and confirm the concept of RA heterogeneity.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12673891

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  13 in total

1.  IL-10-induced gp130 expression in mouse mast cells permits IL-6 trans-signaling.

Authors:  Daniel Traum; Patricia Timothee; Jonathan Silver; Stefan Rose-John; Matthias Ernst; David F LaRosa
Journal:  J Leukoc Biol       Date:  2011-12-02       Impact factor: 4.962

2.  Common carotid intima-media thickness and von Willebrand factor serum levels in rheumatoid arthritis female patients without cardiovascular risk factors.

Authors:  Leonel Daza; Martin Aguirre; Martin Jimenez; Rafael Herrera; J J Bollain
Journal:  Clin Rheumatol       Date:  2006-06-07       Impact factor: 2.980

3.  Low circulating soluble interleukin 2 receptor level predicts rapid response in patients with refractory rheumatoid arthritis treated with infliximab.

Authors:  A Kuuliala; R Nissinen; H Kautiainen; H Repo; M Leirisalo-Repo
Journal:  Ann Rheum Dis       Date:  2005-06-07       Impact factor: 19.103

4.  Interleukin-6 levels in synovial fluids of patients with rheumatoid arthritis correlated with the infiltration of inflammatory cells in synovial membrane.

Authors:  Tomoko Matsumoto; Toshiyuki Tsurumoto; Hiroyuki Shindo
Journal:  Rheumatol Int       Date:  2006-10       Impact factor: 2.631

Review 5.  Inflammatory markers in population studies of aging.

Authors:  Tushar Singh; Anne B Newman
Journal:  Ageing Res Rev       Date:  2010-12-08       Impact factor: 10.895

6.  Plasma soluble IL-6 receptor concentration in rheumatoid arthritis: associations with the rs8192284 IL6R polymorphism and with disease activity.

Authors:  Luis Rodríguez-Rodríguez; José Ramón Lamas; Jezabel Varadé; Pedro López-Romero; Pilar Tornero-Esteban; Lydia Abasolo; Emilio Gomez de la Concha; Juan Angel Jover; Elena Urcelay; Benjamín Fernández-Gutiérrez
Journal:  Rheumatol Int       Date:  2010-07-27       Impact factor: 2.631

7.  Concentration of soluble interleukin-6 receptors in tears of allergic conjunctival disease patients.

Authors:  Jun Shoji; Atsuri Kawaguchi; Aki Gotoh; Noriko Inada; Mitsuru Sawa
Journal:  Jpn J Ophthalmol       Date:  2007-10-05       Impact factor: 2.447

8.  Biomarkers of inflammation and development of rheumatoid arthritis in women from two prospective cohort studies.

Authors:  Elizabeth W Karlson; Lori B Chibnik; Shelley S Tworoger; I-Min Lee; Julie E Buring; Nancy A Shadick; Joann E Manson; Karen H Costenbader
Journal:  Arthritis Rheum       Date:  2009-03

Review 9.  Microarray profiling of lymphocytes in internal diseases with an altered immune response: potential and methodology.

Authors:  Anatoliy Gladkevich; S Adriaan Nelemans; Henk F Kauffman; Jakob Korf
Journal:  Mediators Inflamm       Date:  2005-12-14       Impact factor: 4.711

Review 10.  On the role of sIL-2R measurements in rheumatoid arthritis and cancers.

Authors:  Anna Maria Witkowska
Journal:  Mediators Inflamm       Date:  2005-08-14       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.